- Filed
- Mar 26, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 20, 2026 | 5.09M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 1.77M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 705.19K sh |
| Capex | FY 2025 · Dec 31, 2025 | $2K |
| Capex | FY 2025 · Dec 31, 2024 | $8K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$15.7M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$24.71M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $10.28M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $16.02M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $5.33M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $7.93M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $16.69M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $5.65M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $8.27M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $5.79M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $8.33M |
| Current Assets | FY 2025 · Dec 31, 2025 | $10.88M |
| Current Assets | FY 2025 · Dec 31, 2024 | $16.07M |
| Total Assets | FY 2025 · Dec 31, 2025 | $11.12M |
| Total Assets | FY 2025 · Dec 31, 2024 | $16.26M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$7.35 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$39.13 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$7.35 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$39.13 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $6.91M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $7.26M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $6.8M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $21.55M |
| Net Income | FY 2025 · Dec 31, 2025 | −$12.97M |
| Net Income | FY 2025 · Dec 31, 2024 | −$27.59M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$13.71M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$28.81M |